Effect of mivazerol on perioperative cardiac complications during non- cardiac surgery in patients with coronary heart disease: The European Mivazerol Trial (EMIT)

Anesthesiology

Volumn 91, Issue 4, 1999, Pages 951-961

  Oliver, Michael F ^a   Goldman, Lee ^b   Julian, Desmond G ^c   Holme, Ingar ^d  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

2 Adrenergic agonist; Cardiac death; General and vascular surgery; Myocardial infarction

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CATECHOLAMINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MIVAZEROL; NITRIC ACID DERIVATIVE;

ADULT; AGED; ARTICLE; BRADYCARDIA; CARDIOVASCULAR RISK; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART INFARCTION; HUMAN; HYPERTENSION; HYPOTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; TACHYCARDIA;

ADRENERGIC ALPHA-AGONISTS; AGED; ANESTHESIA, GENERAL; CORONARY DISEASE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMIDAZOLES; INTRAOPERATIVE COMPLICATIONS; MALE; PLACEBOS; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; SURGICAL PROCEDURES, OPERATIVE; SYMPATHOLYTICS; VASCULAR SURGICAL PROCEDURES;

EID: 0032829078     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199910000-00014     Document Type: Article

References (23)

1. Udelsman R, Norton JA, Jelenich SE, Goldstein DS, Linchar WM, Loriaux DL, Chrousos GP: Responses of the hypothalamic-pituitary-adrenal and renin-angiotensin axes and the sympathetic system during controlled surgical and anesthetic stress. J Clin Endocrinol Metab 1987; 64:986-94
2. Mangano DT, Goldman L: Preoperative assessment of patients with known or suspected coronary disease. N Engl J Med 1995; 333: 1750-56
3. Goldman L: Cardiac risk in non-cardiac surgery: An update. Anesth Analg 1995; 80:810-20
4. Tonner PH, Scholz J: Clinical perspectives of alpha-2 adrenoreceptor agonists. Curr Opin Anaesthesiol 1996; 9 :471-80
5. Flacke JW: Alpha-2 adrenergic agonist in cardiovascular anesthesia. J Cardiovasc Anesth 1992; 6:344-59
6. Noyer M, De Laveleye F, Vauquelin G, Gobert J, Wülfert E: Mivazerol, a novel compound with high specificity for α2 adrenergic receptors: Binding studies on different human and rat membrane preparations. Neurochem Int 1994; 24:221-9
7. Kim SY, Raikoff K, Wülfert E. Hanin I: Mivazerol, a selective α2 agonist, attenuates tachycardia by intrathecal injection of N-methyl-D-aspartate in the rat. Eur J Pharmacol 1996; 316:249-52
8. Guyaux M, Gobert J, Noyer M, Vanderville M, Wülfert E: Mivazerol prevents the tachycardia caused by emergence from halothane anaesthesia, partly through activation of spinal α2-adrenoreceptors. Acta Anaesthesiol Scand 1997; 42:238-45
9. Kharkevitch T, Guyaux M, Gobert J, Wülfert E: Mivazerol, a new alpha-2 receptor agonist reduces ischaemia produced by coronary occlusion in rats and dogs. Cardiothorac Drugs Ther 1991; 5:S3,407
10. Wright RA, Decroly P, Kharkcvitch T, Oliver MF: Exercise tolerance in angina is improved by mivazerol, an alpha-2 adrenoceptor agonist. Cardiovasc Drugs Ther 1993; 7: 929-34
11. McSPI-Europe Research Group: Perioperative sympatholysis. Beneficial effects of the α2-adrenoceptor agonist mivazerol on hemodynamic stability and myocardial ischemia. ANESTHESIOLOGY 1997; 86: 346-63
12. O'Brien PC, Fleming TR: A multiple testing procedure for clinical trials. Biometrics 1979; 35:549-56
13. Eagle KA, Rihal CS, Mickel MC, Holmes DR, Foster ED, Gersh BJ: Cardiac risk of non-cardiac surgery: Influence of coronary disease and type of surgery in 3368 operations. Circulation 1997; 96:1882-7
14. Ashton CM: Perioperative myocardial infarction with non-cardiac surgery. Am J Med Sci 1994; 308(1):41-8
15. ACC/AHA Task Force Report: Guidelines for perioperative cardiovascular evaluation for non-cardiac surgery. Circulation 1996; 93: 1278-317
16. Cohen AT: Prevention of perioperative myocardial ischaemia and its complications. Lancet 1998; 351:385-6
17. Ghignone M, Cavallo O, Quintin L: Anesthesia and hypertension: The effect of clonidine on perioperative on perioperative hemodynamics and isoflurane requirements. ANESTHESIOLOGY 1987; 67:3-10
18. Talke P, Li J, Jain U, Leung JL, Drasner K, Hollenberg M, Mangano DT: Effects of perioperative dexmedetomidine infusion in patients undergoing vascular surgery. ANESTHESIOLOGY 1995; 82:620-33
19. Coriat P, Daloz M, Bousseau D, Fusciardi J, Echter E, Viars P: Prevention of intraoperative myocardial ischemia during non-cardiac surgery with intravenous nitroglycerin. ANESTHESIOLOGY 1984; 61:193-6
20. Godet G, Coriat P, Baron JF, Bertrand M, Diquet B, Sebag C, Viars P: Prevention of intraoperative myocardial ischemia during non-cardiac surgery with intravenous diltiazem: A randomized trial versus placebo. ANESTHESIOLOGY 1987; 66:241-5
21. Pasternack PF, Grossi EA, Baumann FG, Riles TS, Lampàrello PJ, Giangola G, Primis LK, Mintzer R, Imparato AM: Beta blockade to decrease silent myocardial ischemia during peripheral surgery. Am J Surg 1989; 158:113-6
22. Stone JG, Foex P, Sear JW, Johnson LL, Khambatta HJ, Triner L: Myocardial ischemia in untreated hypertensive patients: Effect of a single small dose of a beta-adrenergic blocking agent. ANESTHESIOLOGY 1988; 88:495-500
23. Mangano DT, Layug EL, Wallace A. Tateo I: Effect of atenolol on mortality and cardiovascular morbidity after non-cardiac surgery. N Engl J Med 1996; 335:1713-20